Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
Statistical Considerations in the Evaluation of Continuous Biomarkers.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics. 2007; 25(7):577-90.
View in:
PubMed
subject areas
Anti-Asthmatic Agents
Asthma
Cost-Benefit Analysis
Decision Support Techniques
Drug Combinations
Female
Humans
Male
Managed Care Programs
Models, Economic
Randomized Controlled Trials as Topic